Body size in relation to cancer of the uterine corpus in 1 million Norwegian women

International Journal of Cancer

Volumn 120, Issue 2, 2007, Pages 378-383

  Bjørge, Tone ^a,b   Engeland, Anders ^a,b   Tretli, Steinar ^c   Weiderpass, Elisabete ^c,d  

^a UNIVERSITY OF BERGEN   (Norway)

^b NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^c CANCER REGISTRY OF NORWAY   (Norway)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Body mass index; Cancer of the uterine corpus; Cohort study; Height; Histology; Norway

Indexed keywords

ESTROGEN;

ADULT; AGED; ARTICLE; BODY HEIGHT; BODY MASS; BODY SIZE; CANCER RISK; CLEAR CELL CARCINOMA; COHORT ANALYSIS; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; FEMALE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIXED TUMOR; NORWAY; OBESITY; PAPILLARY CARCINOMA; PRIORITY JOURNAL; UTERUS CANCER; UTERUS SARCOMA;

ADULT; AGED; BODY MASS INDEX; BODY SIZE; FEMALE; HUMANS; MIDDLE AGED; NORWAY; RISK; UTERINE NEOPLASMS;

EID: 33845667980     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.22260     Document Type: Article

References (36)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
2. Bray F, Dos Santos Silva I, Moller H, Weiderpass E. Endometrial cancer incidence trends in Europe: underlying determinants and prospects for prevention. Cancer Epidemiol Biomarkers Prev 2005;14:1132-42.
3. The Cancer Registry of Norway. The Cancer Registry of Norway. Available at www.kreftregisteret.no/ (accessed 1 March 2005).
4. International Agency for Research on Cancer (IARC) Working Group on the Evaluation of Cancer-Preventive Strategies, Weight control and physical activity, vol. 6. Lyon: IARC Press, 2002.1-315.
5. Gunnell D, Okasha M, Smith GD, Oliver SE, Sandhu J, Holly JM. Height, leg length, and cancer risk: a systematic review. Epidemiol Rev 2001;23:313-42.
6. Jonsson F, Wolk A, Pedersen NL, Lichtenstein P, Terry P, Ahlbom A, Feychting M. Obesity and hormone-dependent tumors: cohort and co-twin control studies based on the Swedish Twin Registry. Int J Cancer 2003;106:594-9.
7. Scheuten LJ, Goldbohm RA, van den Brandt PA. Anthropometry, physical activity, and endometrial cancer risk: results from the Netherlands Cohort Study. J Natl Cancer Inst 2004;96:1635-8.
8. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-17.
9. Silverberg SG, Kurman RJ, Nogales F. Tumours of the uterine corpus. Epithelial tumours and related lesions. In: Tavassoli FA, Devilee P, eds. Pathology and genetics. Tumours of the breast and female genital organs. Lyon: IARC Press. 2003.221-32,
10. Sherman ME. Theories of endometrial carcinogenesis: a multidisciplinary approach. Mod Pathol 2000;13:295-308.
11. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002;11:1531-43.
12. Engeland A, Tretli S, Bjørge T. Height and body mass index in relation to esophageal cancer; 23-year follow-up of two million Norwegian men and women. Cancer Causes Control 2004;15:837-43.
13. Waaler HT. Height, weight and mortality. The Norwegian experiment. Acta Med Scand Suppl 1984;679:1-56.
14. Bjartveit K, Foss OP, Gjervig T, Lund-Larsen PG. The cardiovascular disease study in Norwegian counties. Background and organization. Acta Med Scand Suppl 1979;634:1-70.
15. Bjartveit K. [The National Health Screening Service: from fight against tuberculosis to many-sided epidemiological activities] Fra tuberkulosekamp til mangesidig epidemiologisk virksomhet. Nor Epidemiol 1997;7:157-74.
16. Statistics Norway. Statistics Norway. Available at www.ssb.no/english/ (accessed January 1, 2004).
17. Emons G, Fleckenstein G, Hinney B, Huschmand A, Heyl W. Hormonal interactions in endometrial cancer. Endocr Relat Cancer 2000;7:227-42.
18. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.1-201.
19. World Health Organization Consultation on Obesity. Preventing and managing the global epidemic: report of a WHO Consultation on Obesity, Geneva, June 3-5, 1997. Geneva, Switzerland: World Health Organization, 1998.1-276.
20. SPSS Inc. SPSS for Windows. Release 12.0.2. March 24, 2004.
21. Insightful Corporation. S-plus 6.1 for Windows. Insightful Corporation. 2002.
22. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005;366:491-505.
23. Kumle M, Alsaker E, Lund E. [Use of oral contraceptives and risk of cancer, a cohort study]. Tidsskr Nor Laegeforen 2003;123:1653-6.
24. Bakken K, Eggen AE, Lund E. Hormone replacement therapy in Norwegian women, 1996-1997. Maturitas 2001;40:131-41.
25. Graff-Iversen S, Stensvold I, Lund-Larsen PG, Nodarse LO, Tverdal A, Urdal P. Serum lipids in postmenopausal or perimenopausal women using estrogen alone, estrogen with levonorgestrel, or estrogen with norethisterone, compared with nonusers: results from a cross-sectional study in two Norwegian counties 1985-1988. J Clin Epidemiol 1998;51:1311-16.
26. Bakken K, Alsaker E, Eggen AE, Lund E. Hormone replacement therapy and incidence of hormone-dependent cancers in the Norwegian women and cancer study. Int J Cancer 2004;112:130-4.
27. Sasco AJ, Secretan MB, Straif K. Tobacco smoking and cancer; a brief review of recent epidemiological evidence. Lung Cancer 2004;45 (Suppl 2):S3-S9.
28. Bergström A, Pisani P, Tenet V, Wolk A, Adami HO. Overweight as an avoidable cause of cancer in Europe. Int J Cancer 2001;91:421-30.
29. Meyer HE, Tverdal A. Development of body weight in the Norwegian population. Prostaglandins Leukot Essent Fatty Acids 2005;73;3-7.
30. Bianchini F, Kaaks R, Vainio H. Overweight, obesity, and cancer risk. Lancet Oncol 2002;3:565-74.
31. Dal Maso L, Augustin LS, Karalis A, Talamini R, Franceschi S, Trichopoulos D, Mantzoros CS, La Vecchia C. Circulating adiponectin and endometrial cancer risk. J Clin Endocrinol Metab 2004;89:1160-3.
32. Housa D, Housova J, Vernerova Z, Haluzik M. Adipocytokines and cancer. Physiol Res 2006;55:233-44.
33. Petridou E, Belechri M, Dessypris N, Koukoulomatis P, Diakomanolis E, Spanos E, Trichopoulos D. Leptin and body mass index in relation to endometrial cancer risk. Ann Nutr Metab 2002;46:147-51.
34. Acharya S, Hensley ML, Montag AC, Fleming GF. Rare uterine cancers. Lancet Oncol 2005;6:961-71.
35. Tretli S, Magnus K. Height and weight in relation to uterine corpus cancer morbidity and mortality. A follow-up study of 570,000 women in Norway. Int J Cancer 1990;46:165-72.
36. Thune I, Olsen AO, Albrektsen G, Tretli S. Cutaneous malignant melanoma: association with height, weight and body-surface area. A prospective study in Norway. Int J Cancer 1993;55:555-61.